AXIM BIOTECHNOLOGIES, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2015 | — | $-1.1M | $195.3K |
| Jun 2015 | — | $843.9K | $31.6K |
| Sep 2015 | — | $-762.7K | $43.3K |
| Dec 2015 | — | $-1.7M | $134.2K |
| Mar 2016 | — | $-2.6M | $171.0K |
| Jun 2016 | — | $-2.8M | $18.6K |
| Sep 2016 | — | $-3.2M | $870.6K |
| Dec 2016 | — | $-2.4M | $713.3K |
| Mar 2017 | — | $-2.9M | $632.4K |
| Jun 2017 | — | $-3.4M | $4.1M |
| Sep 2017 | — | $-4.9M | $3.1M |
| Dec 2017 | — | $-6.3M | $2.1M |
| Mar 2018 | — | $-7.8M | $725.6K |
| Jun 2018 | — | $-7.0M | $515.2K |
| Sep 2018 | — | $-6.2M | $632.2K |
| Dec 2018 | — | $-6.1M | $1.8M |
| Mar 2019 | — | $-5.3M | $2.7M |
| Jun 2019 | — | $-6.2M | $2.2M |
| Sep 2019 | — | $-6.2M | $1.2M |
| Dec 2019 | — | $-6.8M | $511.6K |
| Mar 2020 | — | $-361.7K | $442.7K |
| Jun 2020 | — | $999.1K | $891.4K |
| Sep 2020 | — | $2.3M | $1.2M |
| Dec 2020 | — | $1.6M | $457.2K |
| Mar 2021 | — | $1.6M | $449.2K |
| Jun 2021 | — | $1.0M | $202.2K |
| Sep 2021 | — | $4.6M | $338.4K |
| Dec 2021 | — | $-2.3M | $453.0K |
| Mar 2022 | — | $-3.4M | $408.0K |
| Jun 2022 | — | $-3.7M | $65.2K |
| Sep 2022 | — | $-4.4M | $163.7K |
| Dec 2022 | — | $-4.8M | $47.3K |
| Mar 2023 | — | $-6.2M | $53.5K |
| Jun 2023 | — | $-9.8M | $97.5K |
| Sep 2023 | — | $-6.0M | $23.2K |
| Dec 2023 | $4.9M | $-7.7M | $156.5K |
| Mar 2024 | — | $-7.4M | $96.7K |
| Jun 2024 | $6.0M | $-9.5M | $6.0K |